Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2006; 12(20): 3275-3282
Published online May 28, 2006. doi: 10.3748/wjg.v12.i20.3275
Published online May 28, 2006. doi: 10.3748/wjg.v12.i20.3275
Figure 1 Quantification of dendritic cell subtypes.
A: Analysis of different patient groups; B: Comparison of HCC patients with or without chronic viral hepatitis.
Figure 2 Phenotypic analysis of myeloid dendritic cells in peripheral blood.
Figure 3 FITC-dextran uptake by mDCs.
Figure 4 Peptide-specific stimulation by mDCs.
Figure 5 Impaired allogeneic MLR stimulation by mDCs from HCC patients.
A: Stimulation index of mDCS from HCC patients and healthy controls; B: Comparison of stimulation index of mDCs derived from healthy controls and patients with or without chronic viral hepatitis.
Figure 6 Impaired cytokine production by mDCs from HCC patients.
- Citation: Ormandy LA, Färber A, Cantz T, Petrykowska S, Wedemeyer H, Hörning M, Lehner F, Manns MP, Korangy F, Greten TF. Direct ex vivo analysis of dendritic cells in patients with hepatocellular carcinoma. World J Gastroenterol 2006; 12(20): 3275-3282
- URL: https://www.wjgnet.com/1007-9327/full/v12/i20/3275.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i20.3275